Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2018-05-22 / Oncol Lett 2018 Jul;16(1):1180-1188Immunotherapy of Hepatocellular Carcinoma
/in Checkpoint-Inhibitors, Dendritic Cells, Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2018-04-20 / Oncol Res Treat 2018;41(5):292-297Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model
/in International Publications, Newcastle Disease Virus /von 2018-04-05 / PLoS ONE 2018;13(4):e0195425Newcastle disease virus strain AF2240 as an oncolytic virus: A review
/in International Publications, Newcastle Disease Virus /von 2018-04-04 / Acta Trop. 2018 Jul;183:126-133Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-03-08 / Exp Ther Med 2018 May;15(5):4522-4530PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-03-05 / J. Clin. Invest. 2018 Apr;128(4):1413-1428Potentiating prostate cancer immunotherapy with oncolytic viruses
/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2018-02-13 / Nat Rev Urol 2018 Apr;15(4):235-250Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
/in International Publications, Newcastle Disease Virus /von 2018-01-31 / Mol. Ther. 2018 04;26(4):1008-1019Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2018-01-09 / Cancer Sci. 2018 Feb;109(2):279-288
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de